ABSTRACT
INTRODUCTION
The tremendous analytical power of the polymerase chain reaction (PCR) has revolutionized the fields of molecular and cell biology in an astonishing manner and enables the analysis of gene structures and functions with an unprecedented speed and accuracy (11) . In particular, the elucidation of promoter elements of genes involved in cell-cycle regulation will enable scientists to get deeper insights into the essential control mechanisms of life and to develop new therapeutical approaches for diseases related thereto. Currently, we are interested in characterizing the regulating sites of the gene encoding centromere protein C ( CENP-C ), which represents a centromeric protein essentially involved in the correct formation of the kinetochore and which has additionally been shown as involved in the control mechanisms of the important G1-phase of the cell cycle (6) . For isolating the CENP-C promoter, we apply current protocols and commercially available kits using the PCR technique. In general, such systems are based upon anchored PCR (4), PCR-mediated genome walking (10, 17) or some sequence tagged site (STS) strategy (9) that makes use of available specific sequence information. However, the latter mostly derives from cDNA sequences, implying one significant disadvantage. Nonfunctional copies of cDNA may exist within the genome as so-called "processed pseudogenes", which derive from reverse transcription of spliced mRNA molecules into cDNA (19) . Since they are nearly homologous to the encoding cDNA of the functional gene, they will be simultaneously amplified by PCR, especially when single copy genes are under investigation (3).
Our approach, as reported herein, overcomes that limitation ( Figure 1 ). Starting by mapping potential splicing sites, which includes testing for consensus sequences of intron/exon boundaries (19) , multiple cDNA primer pairs flanking a putative first splicing site are tested in standardized PCR with genomic DNA as a template for the occurrence of an amplification product comprising intron 1 ( Figure 1, step 1 ). Cloning and sequencing of the amplified intron DNA then permits deduction of suitable intron primers, which will be combined with upstream primers deriving from exon 1 or the 5 ′ untranslated region (UTR) in a further nested round of PCR ( Figure 1, step 2 ). Gene specificity of this second PCR step is a necessary presupposition for the successful screening of genomic libraries for promoter regions. Applying such a pretested gene-specific primer pair in a PCR-mediated genomic screening of, i.e., cosmid or P1 bacteriophage-derived artificial chromosomes (PAC) libraries (5), enables the isolation and characterization of clones potentially comprising the anticipated promoter elements ( Figure 1 , steps 3-5). Concerning its usefulness and potential limitations, this strategy was tested in comparison with the commercially available PromoterFinder ™ DNA Walking Kits to specifically amplify and isolate the promoter elements of the single-copy gene encoding CENPCfrom two mammalian species (7, 12) .
MATERIALS AND METHODS

Enzymes, Chemicals and Kits
Restriction endonucleases, Klenow fragment of DNA Polymerase I, T4 DNA Ligase and the T7 DNA Sequenc -
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BioTechniques 26: 718-726 (April 1999) ing Kit were purchased from Amersham Pharmacia Biotech (Freiburg, Germany); oligodeoxynucleotides and the DIG Labeling and Detection Kit were obtained from Boehringer Mannheim GmbH (Mannheim, Germany); Taq DNA Polymerase was from PE Biosystems (Ueberlingen, Germany); acrylamide, isopropyl β -D -thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl-β -D -galactopyranoside (X-gal) and XL1-Blue Competent Cells were from Stratagene (Heidelberg, Germany); agarose was from Life Technologies (Eggenstein, Germany); the QIAEX™II Gel Extraction Kit was from Qiagen GmbH (Hilden, Germany); Biodyne ® A Hybridization Filters were from Pall Gelman Laboratory, (Dreieich, Germany); pGEM ® -T cloning vector was from Promega (Heidelberg, Germany); pUC18 cloning vector and Eco RI ligation adapters were from Appligene (Heidelberg, Germany); the Human and Mouse PromoterFinderDNA Walking Kits and HeLa genomic DNA were purchased from CLONTECH Laboratories (Heidelberg, Germany); PCR and sequencing primers were synthezised by the German Cancer Research Center DNA Core Facility (Heidelberg, Germany).
Nested Primer PCR Applying a PromoterFinder Kit and cDNAderived Primers
Applying the Human PromoterFinder DNA Walking Kit, a gene-specific primer, HAS1, deriving from the reported cDNA sequence of human CENP-C(12) was tested in combination with a kit adapter primer (AP1) in a first round of PCR (Table 1, B) . For that purpose, human genome libraries Likewise, screening for the promoter elements of murine CENP-C was carried out, applying the Mouse PromoterFinder DNA Walking Kit, together with gene-specific primers MAS1 and MAS2, again in combination with adapter primers AP1 and AP2 (Table 1, A) . For this experiment, an annealing temperature of 60°C was chosen in the first round of PCR, which was increased to 65°C in the succeeding nested PCR. Finally, the amplification products of the nested PCRs were analyzed on a 0.7% agarose gel and purified by the QIAEX II Extraction Kit as recommended by the manufacturer.
Alternative PCR-Mediated Screening Applying a cDNA/Intron Primer Combination
In a preliminary PCR that was carried out with minor modifications as described before, 1 µ g of HeLa genom- Figure 1 . Alternative PCR strategy to screen for promoter elements. Reflecting the probability of bases at intron/exon boundaries following the reported consensus motifs (19) , in a first round of PCR, intron 1 is amplified using primers flanking the first putative splicing site within the coding region of a gene of interest (step 1). Following sequencing of intron 1, the combination of an intron primer together with an upstream primer derived from cDNA enables the specific amplification of the 5 ′ region of the gene (step 2), avoiding co-amplification of possibly existing pseudogenes. Specificity of this primer combination can then be used in a PCR-mediated sceening of large genomic DNA clones for the anticipated promoter elements, for example, by screening PAC clones (step 3). Finally, subcloning of the latter (step 4) and PCR testing of resulting DNA fragments with the primer combinations initially used permits the identification of clones potentially comprising promoter elements step 5, which will be further characterized.
ic DNA served as a template in combination with gene-specific primers S1 and AS2. The latter derived from the 5 ′ end of the reported cDNA sequence encoding human CENP-C flanking the putative first splicing site (12) . Applying thermal cycling conditions of 1 min at 94°C, 1 min at 57°C and 2 min 30 s at 72°C, 45 total cycles of PCR were performed, which were followed by gel electrophoresis and QIAEX II purification of the amplification products as before. Sequence determination of the resulting intron 1 sequence allowed the selection of an intron-derived primer, ASI3, which was combined with cDNA primer S1 in a second PCR under identical conditions (Table 1, C). Since this amplification step appeared to be highly specific, the primer pair S1/ASI3 was chosen for the PCR-mediated screening for the anticipated promoter elements. For this purpose, a PAC library representing the human genome was screened on commission at Genome Systems (St. Louis, MO, USA), again applying identical PCR conditions as we established.
Cloning of PCR Amplification Products and Sequence Analysis
Specific DNA amplification products were extracted from agarose gels and ligated without further processing in the pGEM-T vector followed by transformation of XL1-Blue Competent Cells according to standard methodology (13) . Recombinant clones grown as white colonies on LB agar treated with IPTG and X-gal before were amplified as overnight cultures, and recombinant DNA was analyzed following plasmid purification according to the alkaline lysis method (2), and Nco I/ Nsi I endonuclease was treated to cut out the cloned inserts.
Positive clones deriving from the PCR-mediated screening of the human PAC library were subjected to plasmid purification according to the manufacturer's protocol (Genome Systems). Subcloning of the PAC inserts was achieved by partial endonuclease digestion with Eco RI, Bgl II and Hin dIII, which was followed by treatment of the resulting DNA fragments with Klenow fragment of DNA polymerase I, first ligation to Eco RI adapters, further ligation in Eco RI-cut and dephosphorylated pUC18 vector and transformation in XL1-Blue Competent Cells. Finally, recombinant PAC subclones were analyzed for the presence of possible promoter elements by standard hybridization methodology (13) . For this purpose, part of the human CENP-C gene that had been amplified before by PCR, applying gene-specific primers S1 and AS2 (Table 1 , C), was labeled by incorporation of digoxigenin and applied as a sensitive probe to screen for subclones comprising the 5 ′ region. Positive subclones were subjected to DNA sequence analysis, which was performed applying the T7 DNA Sequencing Kit based upon the Sanger method (14) . Finally, evaluation of potential binding motifs for transcription factors and partial sequence homologies between the murine and human CENP-C promoter sequences were achieved applying FACTOR and MA-LIGN algorithms within Heidelberg Unix Sequence Analysis Resources (HUSAR) databases.
RESULTS AND DISCUSSION
Identification of the CENP-C Promoter from Mouse Genomic DNA
By applying the Mouse PromoterFinder DNA Walking Kit in combination with cDNA-derived primers MAS1 and MAS2, we obtained a specific 0.7-kb DNA amplification product following the nested PCR step (Table 1 , A). Sequence determination revealed 570 bp upstream of the known 5 ′ end of the reported murine CENP-C cDNA (7), thus possibly reflecting a substantial part of the anticipated mouse promoter. By searching for binding sites of known basal transcription factors, we mapped several regions rich in G/C base pairing (potential SP1 binding sites) and also mapped the putative CCAAT box (Figure 3 ). Within the murine promoter, we could not map a TATA box, which corresponds to the functions of CENP-C in cell-cycle regulation (6) . Essentially, the necessary regulatory elements reflecting the core Figure 2 . Amplification and cloning of the promoter elements of the human CENP-Cgene. Applying two cDNA primers S1 and AS2 with HeLa genomic DNA as a template in a preliminary PCR, a 1.3-kb amplification product comprising intron 1 was obtained (lane 2). This permits the specific amplification of 193 bp in a second PCR, again applying primer S1 in combination with intron primer ASI3 representing a part of the 5 ′ region of the CENP-Cgene (lane 3). The PCR-mediated PAC library screening using the latter primer combination was followed by appropriate subcloning of a positive clone with a 120-kb insert; resulting DNA fragments were further characterized by PCR and colony hybridization. One subclone containing a 3.8-kb insert (lane 5) comprised the anticipated promoter elements upstream of the known 5 ′ cDNA end. As compared with lanes 2 and 3, PCR again applying primer combinations S1/AS2 (lane 6) and S1/ASI3 (lane 7) revealed specific amplification of the expected known DNA sizes. Applied molecular weight markers were λ phage-digested with Eco RI and Hin dIII (lanes 1 and 8) and pBR322-digested with Alu I (lane 4).
promoter site of the CENP-C gene from mouse were successfully isolated using the commercial promoter finder kit, together with cDNA-derived, genespecific primers.
Failure in Amplifying the Human CENP-C Promoter by Nested PCR Based Upon cDNA Primers Only
Likewise, we tried to isolate the human CENP-C promoter sequence applying the Human PromoterFinder DNA Walking Kit in combination with primers HAS1 and HAS2 deriving from the reported human cDNA sequence (12) . In spite of the specific amplification of 1.4 kb of DNA (Table 1 , B), this amplification product shows the nonfunctional processed pseudogene of the human CENP-Cgene. The latter was confirmed by identifying about 1.3 kb of the encoding sequence of human CENP-Cthat revealed no intron information at all. In addition, we mapped numerous point mutations, both within the short 5 ′ UTR and the encoding sequence, one of them representing a premature stop codon at position 78 of the deduced primary sequence.
In principle, amplification of the promoter region deriving from the functional CENP-Cgene should have been successful, at least to some minor extent. Within the already known 5 ′ region of the human cDNA sequence, none of the restriction sites that were used in cloning the promoter finder kits (which might have prevented the amplification of the promoter region) could be mapped. Neither, could specificity of primer annealing be blamed, since the amplified pseudogene sequence of CENP-C represented the only detectable amplification product in gel electrophoresis. Therefore, it seems likely that within the human genome, the number of existing pseudogenes deriving from CENP-C significantly outnumbers the two functional alleles. As a result, the dominant pseudogene amplification products revealed by gel electrophoresis gave the impression that the PCR experiment was successful, and consequently, were cloned instead of the anticipated promoter.
Application of a cDNA/Intron Primer Combination Improves Specificity of PCR Amplification Using Genomic DNA as a Template
Our approach to identify the human CENP-C promoter by PCR started by establishing some gene-specific intron sequence information to avoid co-amplification or preferred amplification of abundant cDNA copies. Analyzing the 5 ′ region of the reported CENP-C cDNA (12), we tested cDNA primer combinations in PCR to deduce the first putative splicing site, using primers that were chosen empirically or by taking into account reported consensus sequences describing intron/exon boundaries (19) . Applying a combination of primers S1/AS2 with HeLa genomic DNA as a template (Figure 1, step 1 and Table 1 , C), we obtained a specific 1.3-kb amplification product (Figure 2, lane 2). The latter was purified and cloned in pGEM-T/XL1 blue followed by sequence determination, which revealed identity with a minor part of the known cDNA of the human CENP-C gene. However, more important was that we could map the 5 ′ and 3 ′ boundaries of the first intron, representing 1133 bp total, which is localized between bases 174 and 175 within the reported cDNA (start codon ATG represents positions 157 to 159). This enabled the design of primers deriving from the 5 ′ end of intron 1, which were used in a second round of PCR in combination with upstream cDNA primers ( Figure 1, step 2) . Again in combination with primer S1, use of the antisense intron primer ASI3 (Table 1 , C) allowed the specific amplification of the expected genomic 193-bp DNA fragment (Figure 2, lane 3) . Thus, we established the presupposition for a successful screening of the searched promoter elements within any genomic library, and in parallel, a probe to immediately test if the CENP-C promoter can be represented in a chosen library or not.
Identification of the Human CENP-C Promoter by PCR-Mediated Screening of a Human PAC Library
Amplifying specifically a 193-bp fragment of the 5 ′ region of the human CENP-Cgene, the primer combination S1/ASI3 was chosen to screen a human PAC library under identical PCR conditions ( Figure 1, step 3) ; this was done on commission at Genome Systems. Two PAC clones with insert sizes of 120 and 110 kb were positive concerning the CENP-Cgene. This was further confirmed by additional PCR testing, again applying the primer combination S1/AS2 (not shown). Following subcloning of the PAC inserts as described (Figure 1, step 4) , one of about 500 colonies that were screened with a probe representing intron 1 remained positive in rescreening. Possessing a 3.8-kb insert size (Figure 2, lane 5 ), the latter was tested in a final round of PCR, repeating once more amplification conditions applying primer combinations S1/AS2 and S1/ASI3 (Figure 1 , step 5). Both PCR tests revealed the existence of the 5 ′ region of the human CENP-C gene, as the resulting DNA pattern confirmed identity with results we obtained earlier (Figure 2 , lanes 6 and 7 as compared with lanes 2 and 3). At first, preliminary sequencing from both ends of the insert cDNA did not reveal any known nucleotide sequences from databases. However, the comparison of existing partial homologies to the established mouse promoter elements and the identification of potential binding sites for transcription factors, i.e., regions rich in G/C base pairing and the CCAAT box (Figure 3 ), supports the successful identification of at least some core region of the human CENP-C promoter.
Advantages and Limitations of the Applied PCR-Based Screening Techniques
Since a preliminary gene mapping had been done, most of the currently existing protocols based on nested PCR or sequence tagged sites (STS) within the genome should guarantee the successful amplification of interesting promoter elements. Comparing the technical side of the PCR strategies we applied, the promoter finder kits and our approach are rather straightforward, convenient and do not require highly sophisticated practical skills. The most important limitation is the necessary specificity of DNA amplification for the gene of interest. Therefore, it is advisable to test different primer combinations beforehand, and then choose the most specific primer pair for the succeeding PCR-mediated screening of genomic libraries.
One major limitation of the PromoterFinder DNA Walking Kits is the maximal length of amplification products one can obtain. Because of the underlying cloning strategy during the production of these kits (8) , identification of genomic fragments larger than 3 or 4 kb is rather unlikely. However, since usually essential gene-regulating sites of promoters can be expected within a short range upstream of the translation start site, this should not reflect a serious problem in the majority of experiments. Otherwise, one might prefer the PCR-mediated screening of large cosmid or PAC clones, which thus far have not been digested by restriction endonucleases. Such clones contain much more substantial gene information, which enables the investigation of sequences far more upstream or of other gene sites of interest without requiring a further round of laborious and time-consuming screening.
Our approach, combining consecutive rounds of PCR with well-established DNA purification and subcloning methodology, proved to be also applicable for the successful identification of promoter elements. It is especially applicable if faster protocols using primers only derived from cDNA sequences do not provide successful identification. The preliminary establishing of the sequence of intron 1 is certainly not completely innovative, but it prevents the amplification of cDNA derived from mRNA transcripts (which can happen to some minor extent) or, even worse, the co-amplification of genomic cDNA copies in form of processed pseudogenes. By using the Human PromoterFinder Kit, we indeed amplified the pseudogene sequence instead of the promoter region. Obviously, the application of PCR primers derived exclusively from the cDNA sequence can prevent the successful identification of genomic sequences 5 ′ of the gene of interest. Besides, the exclusive total use of three gene-specific primers in our approach as compared with the use of only two in other protocols (4, 10, 17) , allows a "real" seminested PCR and thus, a "walking-like" approach with improved specificity of priming. A further advantage with our approach is represented by establishing the sequence of intron 1, which permits the identification of gene-regulating sites therein; this has been reported for an increasing number of genes. It might be difficult to directly achieve the amplification of intron 1. First of all, cDNA base pairs flanking splicing sites frequently do not follow the reported consensus sequences for intron/exon boundaries (19) , which makes it advisable to test in parallel with empirically chosen primer combinations to get an idea of the exact localization of intron 1. Secondly, since some genes comprise extremely large intron sizes, as for example the complement factor I gene with 36 kb (18) and the human thrombin receptor gene with 22 kb (15) , it might be rather difficult or even impossible to amplify the full length of the first intron sequence. Newly developed expanded PCR techniques (1) applying long PCR kits (i.e., TaKaRa) may help overcome that problem. However, for unknown reasons that might be due to failures of priming in PCR, using that technique, we did not achieve amplification of a genome fragment of CENPCcomprising both introns 1 and 2. Naturally, it is sufficient to determine only a part of the 5 ′ region of intron 1 to get the information necessary for the design of suitable intron primers.
In summary, we conclude that our approach might be helpful to overcome difficulties occuring with currently available protocols that are not predictable when starting a promoter search. Therefore, we recommend it as an attractive alternative, especially when other PCR-based strategies fail in doing so.
